PMID- 36571426 OWN - NLM STAT- MEDLINE DCOM- 20230124 LR - 20230203 IS - 2146-3131 (Electronic) IS - 2146-3123 (Print) IS - 2146-3123 (Linking) VI - 40 IP - 1 DP - 2023 Jan 23 TI - Silencing SOX11 Alleviates Allergic Rhinitis by Inhibiting Epithelial-Derived Cytokines. PG - 57-65 LID - 10.4274/balkanmedj.galenos.2022.2022-9-31 [doi] AB - BACKGROUND: Allergic rhinitis is a chronic inflammatory disease of the nasal mucosa affecting the quality of life of patients. SRY-box transcription factor 11 (SOX11) was reported to play important roles in inflammatory responses, but its role in AR is poorly understood. AIMS: To explore the role of SOX11 in the development of allergic rhinitis. STUDY DESIGN: Cell culture and animal study. METHODS: An in vivo murine allergic rhinitis model was established using ovalbumin treatment in female mice. Interleukin-13-stimulated human nasal mucosa epithelial cells were used for in vitro studies. Expression levels of SOX11, epithelial-derived cytokines, and mucin were determined in both modesls. RESULTS: SOX11 was highly expressed in allergic rhinitis mice. Allergy symptoms, serum ovalbumin-specific IgE, histamine, eosinophils, goblet cells, and type 2 cytokine secretion were increased in ovalbumin-treated mice. Furthermore, allergic rhinitis mice exhibited overproduction of epithelial-derived cytokines (thymic stromal lymphopoietin, interleukin-25, interleukin-33), C-C motif chemokine ligand 26 (CCL26), and mucin 5 AC (MUC5AC). Silencing SOX11 alleviated the behavioral symptoms and upregulation of epithelial-derived cytokines, CCL26, and MUC5AC. In human nasal mucosa epithelial cells, interleukin-13 enhanced SOX11 expression in a time-dependent manner, and signal transducer and activator of transcription 6 (STAT6) was involved in the interleukin-13-mediated expression of SOX11 by regulating transcription. Knockdown of SOX11 reduced epithelial-derived cytokine expression and MUC5AC levels in interleukin-13-treated human nasal mucosa epithelial cells. CONCLUSION: SOX11 plays a critical role in allergic rhinitis development by regulating epithelial-derived cytokines and might be a new therapeutic target for allergic rhinitis. FAU - Jiang, Li AU - Jiang L AUID- ORCID: 0000-0001-7397-9967 AD - Department of Otolaryngology Head and Neck Surgery, The First Affiliated Hospital of Harbin Medical University, Heilongjiang, China FAU - Wang, Chunrui AU - Wang C AUID- ORCID: 0000-0003-3168-1956 AD - Department of Otolaryngology Head and Neck Surgery, The First Affiliated Hospital of Harbin Medical University, Heilongjiang, China FAU - Zhao, Rui AU - Zhao R AUID- ORCID: 0000-0002-6602-6583 AD - Department of Otolaryngology Head and Neck Surgery, The Second Affiliated Hospital of Harbin Medical University, Heilongjiang, China FAU - Cao, Jing AU - Cao J AUID- ORCID: 0000-0001-9304-3189 AD - Department of Otolaryngology Head and Neck Surgery, The Second Affiliated Hospital of Harbin Medical University, Heilongjiang, China FAU - Liu, Yaohui AU - Liu Y AUID- ORCID: 0000-0002-1377-6911 AD - Department of Otolaryngology Head and Neck Surgery, The Second Affiliated Hospital of Harbin Medical University, Heilongjiang, China FAU - Tian, Linli AU - Tian L AUID- ORCID: 0000-0002-8934-1607 AD - Department of Otolaryngology Head and Neck Surgery, The Second Affiliated Hospital of Harbin Medical University, Heilongjiang, China FAU - Liu, Ming AU - Liu M AUID- ORCID: 0000-0002-4098-6631 AD - Department of Otolaryngology Head and Neck Surgery, The Second Affiliated Hospital of Harbin Medical University, Heilongjiang, China LA - eng PT - Journal Article DEP - 20221226 PL - Turkey TA - Balkan Med J JT - Balkan medical journal JID - 101571817 RN - 0 (Cytokines) RN - 0 (Interleukin-13) RN - 9006-59-1 (Ovalbumin) RN - 0 (Mucins) RN - 0 (SOX11 protein, human) RN - 0 (SOXC Transcription Factors) RN - 0 (Sox11 protein, mouse) SB - IM MH - Humans MH - Female MH - Mice MH - Animals MH - *Cytokines/metabolism/therapeutic use MH - Interleukin-13/pharmacology/therapeutic use MH - Ovalbumin/pharmacology/therapeutic use MH - Quality of Life MH - *Rhinitis, Allergic MH - Mucins/therapeutic use MH - SOXC Transcription Factors PMC - PMC9874254 COIS- Conflict of Interest: No conflict of interest was declared by the authors. Funding: The authors declared that this study received no financial support. EDAT- 2022/12/27 06:00 MHDA- 2023/01/25 06:00 PMCR- 2023/01/23 CRDT- 2022/12/26 08:15 PHST- 2022/12/26 08:15 [entrez] PHST- 2022/12/27 06:00 [pubmed] PHST- 2023/01/25 06:00 [medline] PHST- 2023/01/23 00:00 [pmc-release] AID - 58388 [pii] AID - 10.4274/balkanmedj.galenos.2022.2022-9-31 [doi] PST - ppublish SO - Balkan Med J. 2023 Jan 23;40(1):57-65. doi: 10.4274/balkanmedj.galenos.2022.2022-9-31. Epub 2022 Dec 26.